Kinsey Adam M, Diederich Chris J, Rieke Viola, Nau William H, Pauly Kim Butts, Bouley Donna, Sommer Graham
Thermal Therapy Research Group, Department of Radiation Oncology, University of California, San Francisco, California 94143, USA.
Med Phys. 2008 May;35(5):2081-93. doi: 10.1118/1.2900131.
The purpose of this study was to explore the feasibility and performance of a multi-sectored tubular array transurethral ultrasound applicator for prostate thermal therapy, with potential to provide dynamic angular and length control of heating under MR guidance without mechanical movement of the applicator. Test configurations were fabricated, incorporating a linear array of two multi-sectored tubular transducers (7.8-8.4 MHz, 3 mm OD, 6 mm length), with three 120 degrees independent active sectors per tube. A flexible delivery catheter facilitated water cooling (100 ml min(-1)) within an expandable urethral balloon (35 mm long x 10 mm diameter). An integrated positioning hub allows for rotating and translating the transducer assembly within the urethral balloon for final targeting prior to therapy delivery. Rotational beam plots indicate approximately 90 degrees-100 degrees acoustic output patterns from each 120 degrees transducer sector, negligible coupling between sectors, and acoustic efficiencies between 41% and 53%. Experiments were performed within in vivo canine prostate (n = 3), with real-time MR temperature monitoring in either the axial or coronal planes to facilitate control of the heating profiles and provide thermal dosimetry for performance assessment. Gross inspection of serial sections of treated prostate, exposed to TTC (triphenyl tetrazolium chloride) tissue viability stain, allowed for direct assessment of the extent of thermal coagulation. These devices created large contiguous thermal lesions (defined by 52 degrees C maximum temperature, t43 = 240 min thermal dose contours, and TTC tissue sections) that extended radially from the applicator toward the border of the prostate (approximately15 mm) during a short power application (approximately 8-16 W per active sector, 8-15 min), with approximately 200 degrees or 360 degrees sector coagulation demonstrated depending upon the activation scheme. Analysis of transient temperature profiles indicated progression of lethal temperature and thermal dose contours initially centered on each sector that coalesced within approximately 5 min to produce uniform and contiguous zones of thermal destruction between sectors, with smooth outer boundaries and continued radial propagation in time. The dimension of the coagulation zone along the applicator was well-defined by positioning and active array length. Although not as precise as rotating planar and curvilinear devices currently under development for MR-guided procedures, advantages of these multi-sectored transurethral applicators include a flexible delivery catheter and that mechanical manipulation of the device using rotational motors is not required during therapy. This multi-sectored tubular array transurethral ultrasound technology has demonstrated potential for relatively fast and reasonably conformal targeting of prostate volumes suitable for the minimally invasive treatment of BPH and cancer under MR guidance, with further development warranted.
本研究的目的是探索一种用于前列腺热疗的多扇区管状阵列经尿道超声探头的可行性和性能,该探头有潜力在磁共振引导下提供加热的动态角度和长度控制,而探头无需机械移动。制造了测试配置,其中包含两个多扇区管状换能器的线性阵列(7.8 - 8.4兆赫兹,外径3毫米,长度6毫米),每根管有三个120度独立的有源扇区。一根柔性输送导管便于在可扩张尿道球囊(长35毫米,直径10毫米)内进行水冷(100毫升/分钟)。一个集成定位枢纽允许在治疗输送前在尿道球囊内旋转和平移换能器组件以进行最终定位。旋转波束图显示每个120度换能器扇区的声学输出模式约为90度 - 100度,扇区之间的耦合可忽略不计,声学效率在41%至53%之间。在体内犬前列腺(n = 3)中进行了实验,在轴向或冠状平面进行实时磁共振温度监测,以利于控制加热曲线并提供热剂量测定用于性能评估。对暴露于TTC(氯化三苯基四氮唑)组织活力染色的治疗后前列腺连续切片进行大体检查,可直接评估热凝固程度。这些装置在短时间通电(每个有源扇区约8 - 16瓦,8 - 15分钟)期间产生了大的连续热损伤(由最高温度52摄氏度、t43 = 240分钟热剂量轮廓和TTC组织切片定义),热损伤从探头径向延伸至前列腺边界(约15毫米),根据激活方案显示出约200度或360度扇区凝固。对瞬态温度曲线的分析表明,致死温度和热剂量轮廓最初以每个扇区为中心发展,在约5分钟内合并,在扇区之间产生均匀且连续的热破坏区域,边界光滑且随时间持续径向扩展。沿探头的凝固区尺寸通过定位和有源阵列长度得到很好的界定。尽管不如目前正在开发用于磁共振引导程序的旋转平面和曲线装置精确,但这些多扇区经尿道探头的优点包括柔性输送导管,并且在治疗期间不需要使用旋转电机对装置进行机械操作。这种多扇区管状阵列经尿道超声技术已显示出在磁共振引导下相对快速且合理适形地靶向适合微创治疗良性前列腺增生和癌症的前列腺体积的潜力,值得进一步开发。